title: Twenty-four-hour power spectral analysis by maximum entropy method of blood pressure in primary hyperaldosteronism.
abstract: In the present study we estimated the periodic profiles and variance structure of systolic blood pressure, diastolic blood pressure, heart rate and mean arterial pressure by using an autoregressive model of power spectrum, Maximum Entropy Method (MEM) in 8 patients with primary aldosteronism, during long-term therapy with nicardipine slow release. The four blood pressure variables were measured at 30-min intervals, using a noninvasive device (Spacelabs 90202) in 8 hypertensive patients of whom 6 with idiopathic aldosteronism (IHA) and 2 with dexamethasone-suppressible aldosteronism (DSH), before and after 24 weeks of 80 mg nicardipine daily. Blood pressure data were processed by MEM and spectral profiles were obtained. During nicardipine therapy all patients showed a significant decrease of 24-h ambulatory blood pressure values (p < 0.01). Before therapy, spectrum analysis by MEM indicated the presence of high frequency distribution of peaks for SBP, DBP, MAP and HR. The MEM power spectrum showed an increase in amplitude of sharp peaks of systolic, diastolic, MAP and heart rate in all patients after therapy at 24 h corresponding to the circadian rhythm blood pressure. Furthermore, the trend of these variables synchronized themselves in the same period after 24 weeks of nicardipine therapy, with spectral patterns of blood pressure similar to those of normotensive subjects. This chronobiologic approach, by Maximum Entropy Method, may be used as an alternative statistical analysis to search for possible rhythmic behavior of ambulatory blood pressure data before and after pharmacological treatment in secondary hypertensive patients.
authors.affiliation: Department of Internal Medicine, S. Vito Hospital, University of Turin, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Veglio
authors.forename: G
authors.initials: G
authors.lastname: Pinna
authors.forename: R
authors.initials: R
authors.lastname: Melchio
authors.forename: F
authors.initials: F
authors.lastname: Rabbia
authors.forename: P
authors.initials: P
authors.lastname: Molino
authors.forename: C
authors.initials: C
authors.lastname: Torchio
authors.forename: L
authors.initials: L
authors.lastname: Chiandussi
mesh_terms: D000204:Activity Cycles / Q000502:physiology; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002940:Circadian Rhythm / Q000502:physiology; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D008991:Monitoring, Physiologic / Q000706:statistics & numerical data; D009529:Nicardipine / Q000627:therapeutic use; D012044:Regression Analysis
chemical_list: D009529:Nicardipine